We are live on ! Find out more
TCT

TIAA CREF Trust Portfolio holdings

AUM $13.8B
1-Year Est. Return 10.67%
This Fund
S&P 500
This Quarter Est. Return
+2.26%
1 Year Est. Return
+10.67%
3 Year Est. Return
+14.84%
5 Year Est. Return
10 Year Est. Return
AUM
$10.9B
AUM Growth
+$648M
Cap. Flow
+$430M
Cap. Flow %
3.95%
Top 10 Hldgs %
53.26%
Holding
357
New
31
Increased
168
Reduced
140
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 2.71%
2 Financials 2.04%
3 Consumer Staples 1.7%
4 Technology 1.7%
5 Industrials 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAA icon
351
Plains All American Pipeline
PAA
$17.2B
-11,333
Closed -$238K
REGN icon
352
Regeneron Pharmaceuticals
REGN
$70.9B
-10,007
Closed -$3.61M
SCHF icon
353
Schwab International Equity ETF
SCHF
$65.4B
-25,414
Closed -$344K
ENDP
354
DELISTED
Endo International plc
ENDP
-16,466
Closed -$463K
BXLT
355
DELISTED
BAXALTA INC COM STK (DE)
BXLT
-15,858
Closed -$641K
MHFI
356
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
-24,072
Closed -$2.38M
CA
357
DELISTED
CA, Inc.
CA
-10,721
Closed -$330K

Similar funds

TIAA CREF Trust's Q2 2016 Portfolio in Review

As of Q2 2016, TIAA CREF Trust held 357 positions worth $10.9B, up 6.3% from $10.2B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

TIAA CREF Trust deployed $430M of net new capital in Q2 2016, opening 31 new positions and adding to 168 existing holdings. Its largest new stake was Amazon: 218,760 shares worth $7.83M.

By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, down from 2.7% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Biogen, an estimated $5.75M trimmed.

  • TIAA CREF Trust's largest Q2 2016 buy was Amazon: 218,760 shares worth $7.83M.
  • TIAA CREF Trust added most to iShares TIPS Bond ETF in Q2 2016, an estimated $60.2M increase.
  • TIAA CREF Trust's biggest Q2 2016 reduction was Biogen, cutting an estimated $5.75M.
  • TIAA CREF Trust fully exited Regeneron Pharmaceuticals in Q2 2016, selling an estimated $3.61M.
  • TIAA CREF Trust's ten largest holdings make up 53% of its $10.9B portfolio in Q2 2016.
  • TIAA CREF Trust opened 31 new positions and closed 12 in Q2 2016.
  • TIAA CREF Trust's portfolio value rose 6.3% quarter-over-quarter to $10.9B.

Based on TIAA CREF Trust's 13F filing for Q2 2016, filed 21 Jul 2016.